The Effectiveness and Safety of High-Dose Colistin: Prospective Cohort Study

Efficacy and Toxicity of High-Dose Colistin in Multidrug-Resistant Gram-Negative Bacilli Infections: A Comparative Study of a Matched Series

(2016) Ahlem Trifi et al.   CHEMOTHERAPY

Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol

(2016) Yaakov Dickstein et al.   BMJ Open

Efficacy and Safety of a Colistin Loading Dose, High-Dose Maintenance Regimen in Critically Ill Patients With Multidrug-Resistant Gram-Negative Pneumonia

(2016) Jessica L. Elefritz et al.   JOURNAL OF INTENSIVE CARE MEDICINE

Influence of Colistin Dose on Global Cure in Patients with Bacteremia Due to Carbapenem-Resistant Gram-Negative Bacilli

(2015) Gabrielle A. Gibson et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

New Colistin Population Pharmacokinetic Data in Critically Ill Patients Suggesting an Alternative Loading Dose Rationale

(2014) N. Grégoire et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

An Ongoing National Intervention to Contain the Spread of Carbapenem-Resistant Enterobacteriaceae

(2013) M. J. Schwaber et al.   CLINICAL INFECTIOUS DISEASES

Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium

(2013) Felipe F. Tuon et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Association Between Colistin Dose and Microbiologic Outcomes in Patients With Multidrug-Resistant Gram-Negative Bacteremia

(2012) Giulia Vicari et al.   CLINICAL INFECTIOUS DISEASES

Updating and Validating the Charlson Comorbidity Index and Score for Risk Adjustment in Hospital Discharge Abstracts Using Data From 6 Countries

(2011) H. Quan et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients

(2011) S. M. Garonzik et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Incidence of and Risk Factors for Colistin-Associated Nephrotoxicity in a Large Academic Health System

(2011) J. M. Pogue et al.   CLINICAL INFECTIOUS DISEASES

Containment of a Country-wide Outbreak of Carbapenem-Resistant Klebsiella pneumoniae in Israeli Hospitals via a Nationally Implemented Intervention

(2011) M. J. Schwaber et al.   CLINICAL INFECTIOUS DISEASES

Colistin pharmacokinetics: the fog is lifting

(2011) W. Couet et al.   CLINICAL MICROBIOLOGY AND INFECTION

Colistin: new lessons on an old antibiotic

(2011) D. Yahav et al.   CLINICAL MICROBIOLOGY AND INFECTION

Colistin Dosing and Nephrotoxicity in a Large Community Teaching Hospital

(2010) C. A. DeRyke et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effectiveness and safety of colistin: prospective comparative cohort study

(2010) Mical Paul et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria

(2009) D. Plachouras et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients

(2009) Matthew E. Falagas et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

CDC/NHSN surveillance definition of health care–associated infection and criteria for specific types of infections in the acute care setting

(2008) Teresa C. Horan et al.   AMERICAN JOURNAL OF INFECTION CONTROL